IL123422A - USE OF 7alpha-METHYL-17alpha-ETHYNYL-ESTRANE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE PROPHYLAXIS OR THE TREATMENT OF ATHEROSCLEROSIS - Google Patents
USE OF 7alpha-METHYL-17alpha-ETHYNYL-ESTRANE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE PROPHYLAXIS OR THE TREATMENT OF ATHEROSCLEROSISInfo
- Publication number
- IL123422A IL123422A IL12342298A IL12342298A IL123422A IL 123422 A IL123422 A IL 123422A IL 12342298 A IL12342298 A IL 12342298A IL 12342298 A IL12342298 A IL 12342298A IL 123422 A IL123422 A IL 123422A
- Authority
- IL
- Israel
- Prior art keywords
- 7alpha
- 17alpha
- ethynyl
- prophylaxis
- atherosclerosis
- Prior art date
Links
- ARRHIZQUNCQPGJ-HQGWOUGASA-N (7r,8r,9r,10s,13s,14s,17s)-17-ethynyl-7,13-dimethyl-1,2,3,4,5,6,7,8,9,10,11,12,14,15,16,17-hexadecahydrocyclopenta[a]phenanthrene Chemical class C([C@@H]12)C[C@]3(C)[C@H](C#C)CC[C@H]3[C@@H]1[C@H](C)CC1[C@@H]2CCCC1 ARRHIZQUNCQPGJ-HQGWOUGASA-N 0.000 title 1
- 201000001320 Atherosclerosis Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000011321 prophylaxis Methods 0.000 title 1
- 238000011282 treatment Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97200646 | 1997-03-05 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL123422A0 IL123422A0 (en) | 1998-09-24 |
| IL123422A true IL123422A (en) | 2003-05-29 |
Family
ID=8228079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12342298A IL123422A (en) | 1997-03-05 | 1998-02-24 | USE OF 7alpha-METHYL-17alpha-ETHYNYL-ESTRANE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE PROPHYLAXIS OR THE TREATMENT OF ATHEROSCLEROSIS |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0994713B1 (xx) |
| JP (1) | JP2001515478A (xx) |
| KR (1) | KR100556558B1 (xx) |
| CN (1) | CN1159014C (xx) |
| AR (1) | AR015371A1 (xx) |
| AT (1) | ATE253366T1 (xx) |
| AU (1) | AU733758B2 (xx) |
| BR (1) | BR9808194A (xx) |
| CA (1) | CA2283418A1 (xx) |
| DE (1) | DE69819503T2 (xx) |
| DK (1) | DK0994713T3 (xx) |
| ES (1) | ES2210731T3 (xx) |
| HU (1) | HUP0001499A3 (xx) |
| IL (1) | IL123422A (xx) |
| NO (1) | NO994305L (xx) |
| PL (1) | PL335904A1 (xx) |
| TR (1) | TR199902510T2 (xx) |
| TW (1) | TW448049B (xx) |
| WO (1) | WO1998039012A1 (xx) |
| ZA (1) | ZA981731B (xx) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19834931A1 (de) * | 1998-07-28 | 2000-02-24 | Jenapharm Gmbh | Verwendung von biogenen Estrogenen zur Hormonsubstitutionstherapie |
| KR20060071897A (ko) * | 1998-10-16 | 2006-06-27 | 엔.브이. 오가논 | (7α,17α)-17-히드록시-7-메틸-19-노르-17-프레근-5(10)-엔-20-인-3-온의 고순도 화합물 및 그 화합물을 포함하는 고순도조성물 |
-
1998
- 1998-02-24 TW TW087102648A patent/TW448049B/zh not_active IP Right Cessation
- 1998-02-24 IL IL12342298A patent/IL123422A/xx not_active IP Right Cessation
- 1998-03-02 ZA ZA981731A patent/ZA981731B/xx unknown
- 1998-03-03 TR TR1999/02510T patent/TR199902510T2/xx unknown
- 1998-03-03 CA CA002283418A patent/CA2283418A1/en not_active Abandoned
- 1998-03-03 BR BR9808194-2A patent/BR9808194A/pt not_active Application Discontinuation
- 1998-03-03 AU AU67284/98A patent/AU733758B2/en not_active Ceased
- 1998-03-03 DK DK98912450T patent/DK0994713T3/da active
- 1998-03-03 KR KR1019997008051A patent/KR100556558B1/ko not_active Expired - Fee Related
- 1998-03-03 WO PCT/EP1998/001293 patent/WO1998039012A1/en not_active Ceased
- 1998-03-03 HU HU0001499A patent/HUP0001499A3/hu unknown
- 1998-03-03 CN CNB988042096A patent/CN1159014C/zh not_active Expired - Fee Related
- 1998-03-03 AT AT98912450T patent/ATE253366T1/de not_active IP Right Cessation
- 1998-03-03 ES ES98912450T patent/ES2210731T3/es not_active Expired - Lifetime
- 1998-03-03 DE DE69819503T patent/DE69819503T2/de not_active Expired - Fee Related
- 1998-03-03 PL PL98335904A patent/PL335904A1/xx unknown
- 1998-03-03 JP JP53817498A patent/JP2001515478A/ja not_active Ceased
- 1998-03-03 EP EP98912450A patent/EP0994713B1/en not_active Expired - Lifetime
- 1998-03-04 AR ARP980100956A patent/AR015371A1/es not_active Application Discontinuation
-
1999
- 1999-09-03 NO NO994305A patent/NO994305L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA981731B (en) | 1998-09-07 |
| CN1252723A (zh) | 2000-05-10 |
| AR015371A1 (es) | 2001-05-02 |
| KR20000075966A (ko) | 2000-12-26 |
| AU733758B2 (en) | 2001-05-24 |
| DE69819503D1 (de) | 2003-12-11 |
| ES2210731T3 (es) | 2004-07-01 |
| HUP0001499A2 (hu) | 2000-11-28 |
| EP0994713B1 (en) | 2003-11-05 |
| CA2283418A1 (en) | 1998-09-11 |
| HUP0001499A3 (en) | 2001-03-28 |
| KR100556558B1 (ko) | 2006-03-06 |
| NO994305D0 (no) | 1999-09-03 |
| PL335904A1 (en) | 2000-05-22 |
| BR9808194A (pt) | 2000-05-16 |
| CN1159014C (zh) | 2004-07-28 |
| NO994305L (no) | 1999-11-01 |
| TR199902510T2 (xx) | 2000-02-21 |
| WO1998039012A1 (en) | 1998-09-11 |
| ATE253366T1 (de) | 2003-11-15 |
| AU6728498A (en) | 1998-09-22 |
| EP0994713A1 (en) | 2000-04-26 |
| TW448049B (en) | 2001-08-01 |
| HK1025510A1 (en) | 2000-11-17 |
| JP2001515478A (ja) | 2001-09-18 |
| IL123422A0 (en) | 1998-09-24 |
| DE69819503T2 (de) | 2004-09-23 |
| DK0994713T3 (da) | 2004-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL174732A0 (en) | Use of crystal modification of a n-phenyl-2-pyrimidineamine derivative in the preparation of a medicament for the treatment of restenosis | |
| HUP0104709A3 (en) | Use of erythropoietin or erythropoietin derivatives for the manufacture of a medicament for treatment of cerebral ischaemia | |
| ZA959100B (en) | Azetidinone derivatives for the treatment of atherosclerosis | |
| HUP9903166A3 (en) | Medicinal compositions for the prophylaxis or treatment of arteriosclerosis | |
| GB2311940B (en) | Pharmaceutical compositions for the treatment of rhinitis | |
| HUP9702042A3 (en) | Use of 1,1,2-triphenil but-1-ene derivatives for the production of medicaments against atherosclerosis | |
| IL119894A (en) | Use of thiazolidine in the preparation of a medicament for the treatment of osteoporosis | |
| IL127496A0 (en) | The use of MMP inhibitors for the treatment of ocular angiogenesis | |
| AU3728095A (en) | Use of zaprinast for the manufacture of a medicament for inhibiting vascular restenosis | |
| AU3187595A (en) | Compounds for the treatment of restenosis | |
| HUP0103826A3 (en) | A process for the preparation of zofenopril calcium salt and medicament containing it and its use | |
| IL121329A0 (en) | A pharmaceutical composition for the treatment of cancer | |
| AU5627796A (en) | Medicaments for the treatment or prophylaxis of ischemia-reperfusion injury | |
| IL120005A (en) | Pharmaceutical compositions for the treatment of the eye | |
| IL123422A (en) | USE OF 7alpha-METHYL-17alpha-ETHYNYL-ESTRANE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE PROPHYLAXIS OR THE TREATMENT OF ATHEROSCLEROSIS | |
| IL130831A0 (en) | Imino-aza-anthracylinone derivatives for the treatment of amyloidosis | |
| IL133739A (en) | Shaped products or structures for medical or related purposes | |
| AU3071799A (en) | Use of pkc inhibitors for the manufacture of a medicament for the treatment of cytomegalovirus infection | |
| AU3071899A (en) | Use of pkc-inhibitors for the manufacture of a medicament for the treatment of asthma | |
| AU1176295A (en) | Orthopedic casts | |
| IL117465A (en) | Use of certain cystine derivatives for the preparation of a medicament for the treatment of restenosis | |
| KR100248098B1 (en) | Pharmaceutical composition for the treatment of dementia | |
| IL130103A0 (en) | The use of a diarylalkane derivative in the manufacture of a medicament for treatment or prevention of pancreatitis | |
| AU1991199A (en) | A preparation for the treatment of aphtae | |
| SI1068184T1 (en) | N-aryloxyethylamine derivatives for the treatment of depression |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees | ||
| MM9K | Patent not in force due to non-payment of renewal fees |